Candriam SCA’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Sell |
124,680
-5,265
| -4% | -$425K | 0.05% | 286 |
|
|
2026
Q1 | $9.19M | Sell |
129,945
-4,219
| -3% | -$316K | 0.05% | 292 |
|
|
2025
Q4 | $10.6M | Buy |
134,164
+57,279
| +74% | +$4.53M | 0.05% | 260 |
|
|
2025
Q3 | $6.33M | Sell |
76,885
-193,802
| -72% | -$15.3M | 0.03% | 332 |
|
|
2025
Q2 | $21.8M | Sell |
270,687
-95,048
| -26% | -$7.33M | 0.13% | 154 |
|
|
2025
Q1 | $29.4M | Sell |
365,735
-108,152
| -23% | -$8.99M | 0.18% | 116 |
|
|
2024
Q4 | $38.8M | Buy |
473,887
+93,338
| +25% | +$7.77M | 0.22% | 91 |
|
|
2024
Q3 | $31.4M | Buy |
380,549
+21,058
| +6% | +$1.57M | 0.18% | 121 |
|
|
2024
Q2 | $25.2M | Buy |
359,491
+230,116
| +178% | +$16.4M | 0.15% | 135 |
|
|
2024
Q1 | $9.59M | Sell |
129,375
-24,887
| -16% | -$1.73M | 0.06% | 261 |
|
|
2023
Q4 | $10.2M | Sell |
154,262
-101,752
| -40% | -$6.37M | 0.07% | 247 |
|
|
2023
Q3 | $16.1M | Buy |
256,014
+160,112
| +167% | +$9.97M | 0.11% | 170 |
|
|
2023
Q2 | $5.42M | Sell |
95,902
-326,386
| -77% | -$18.1M | 0.04% | 322 |
|
|
2023
Q1 | $22.5M | Sell |
422,288
-454,054
| -52% | -$30.6M | 0.16% | 149 |
|
|
2022
Q4 | $63.4M | Buy |
876,342
+434,814
| +98% | +$31.1M | 0.43% | 54 |
|
|
2022
Q3 | $26.8M | Buy |
441,528
+265,366
| +151% | +$17M | 0.19% | 119 |
|
|
2022
Q2 | $11.1M | Buy |
176,162
+115,977
| +193% | +$7.68M | 0.09% | 212 |
|
|
2022
Q1 | $4.23M | Sell |
60,185
-2,647
| -4% | -$179K | 0.03% | 383 |
|
|
2021
Q4 | $3.93M | Sell |
62,832
-5,813
| -8% | -$365K | 0.03% | 404 |
|
|
2021
Q3 | $4.24M | Sell |
68,645
-68,043
| -50% | -$4.1M | 0.03% | 425 |
|
|
2021
Q2 | $8.18M | Sell |
136,688
-174,441
| -56% | -$11.1M | 0.06% | 314 |
|
|
2021
Q1 | $14M | Buy |
311,129
+1
| +0% | +$55 | 0.12% | 194 |
|
|
2020
Q4 | $14.6M | Buy |
311,128
+49,337
| +19% | +$2.14M | 0.12% | 196 |
|
|
2020
Q3 | $9.73M | Buy |
261,791
+7,297
| +3% | +$277K | 0.09% | 243 |
|
|
2020
Q2 | $9.29M | Sell |
254,494
-141,396
| -36% | -$4.92M | 0.1% | 223 |
|
|
2020
Q1 | $19.7M | Buy |
395,890
+44
| +0% | +$1.95K | 0.22% | 102 |
|
|
2019
Q4 | $20.2M | Buy |
395,846
+59,399
| +18% | +$2.87M | 0.22% | 102 |
|
|
2019
Q3 | $15.9M | Sell |
336,447
-10,803
| -3% | -$515K | 0.21% | 109 |
|
|
2019
Q2 | $18.7M | Sell |
347,250
-44,896
| -11% | -$2.11M | 0.23% | 98 |
|
|
2019
Q1 | $18M | Sell |
392,146
-19,783
| -5% | -$875K | 0.23% | 97 |
|
|
2018
Q4 | $16.9M | Sell |
411,929
-9,502
| -2% | -$408K | 0.26% | 84 |
|
|
2018
Q3 | $19.7M | Buy |
421,431
+47,269
| +13% | +$2.16M | 0.26% | 91 |
|
|
2018
Q2 | $16.3M | Buy |
374,162
+189,093
| +102% | +$8.82M | 0.26% | 94 |
|
|
2018
Q1 | $8.49M | Buy |
185,069
+96,396
| +109% | +$4.68M | 0.14% | 185 |
|
|
2017
Q4 | $4.48M | Sell |
88,673
-13,892
| -14% | -$732K | 0.08% | 287 |
|
|
2017
Q3 | $5.33M | Sell |
102,565
-6,377
| -6% | -$311K | 0.09% | 253 |
|
|
2017
Q2 | $5.33M | Sell |
108,942
-9,948
| -8% | -$461K | 0.1% | 239 |
|
|
2017
Q1 | $5.6M | Buy |
118,890
+26,628
| +29% | +$1.27M | 0.11% | 226 |
|
|
2016
Q4 | $4.43M | Buy |
92,262
+54,025
| +141% | +$2.48M | 0.1% | 231 |
|
|
2016
Q3 | $1.51M | Buy |
38,237
+1,628
| +4% | +$61.2K | 0.04% | 411 |
|
|
2016
Q2 | $1.3M | Sell |
36,609
-15,067
| -29% | -$588K | 0.03% | 387 |
|
|
2016
Q1 | $2.01M | Sell |
51,676
-5,984
| -10% | -$224K | 0.05% | 319 |
|
|
2015
Q4 | $2.48M | Sell |
57,660
-185,618
| -76% | -$8.16M | 0.07% | 268 |
|
|
2015
Q3 | $10.2M | Sell |
243,278
-21,668
| -8% | -$1.01M | 0.25% | 120 |
|
|
2015
Q2 | $13.2M | Buy |
264,946
+225,216
| +567% | +$10.7M | 0.28% | 102 |
|
|
2015
Q1 | $1.79M | Sell |
39,730
-64,340
| -62% | -$2.89M | 0.04% | 404 |
|
|
2014
Q4 | $5.02M | Buy |
+104,070
| New | +$4.94M | 0.1% | 230 |
|
Other funds holding MET
Candriam SCA's MET Position: Q2 2026 in Review
Candriam SCA reduced its MetLife (MET) stake by 4.1% in Q2 2026, selling an estimated $425K and leaving 124,680 shares worth $10.5M. The position accounts for 0.05% of the portfolio, ranked #286.
Candriam SCA first reported a position in MET in Q4 2014 and has held it in 47 quarters since. The position peaked at $63.4M in Q4 2022. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Candriam SCA held 124,680 shares of MetLife worth $10.5M as of Q2 2026.
- Candriam SCA sold 5,265 MetLife shares in Q2 2026, an estimated $425K.
- MetLife made up 0.05% of Candriam SCA's portfolio in Q2 2026, its #286 holding.
- Candriam SCA first reported a position in MetLife in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's MetLife position peaked at $63.4M in Q4 2022.
- 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.